These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17052822)

  • 1. Contributions of the Norwegian Institute of Public Health to the development of vaccines against serogroup B meningococcal disease.
    Rosenqvist E; Holst J; Nøkleby H
    Vaccine; 2007 Jan; 25(6):965-6. PubMed ID: 17052822
    [No Abstract]   [Full Text] [Related]  

  • 2. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
    Soriano-Gabarró M; Rosenstein N; LaForce FM
    J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026
    [No Abstract]   [Full Text] [Related]  

  • 6. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved meningitis vaccine for Africa could signal eventual end to deadly scourge.
    Wkly Epidemiol Rec; 2007 Jun; 82(24):222-4. PubMed ID: 17571448
    [No Abstract]   [Full Text] [Related]  

  • 8. Meningococcal disease: risk for international travellers and vaccine strategies.
    Wilder-Smith A
    Travel Med Infect Dis; 2008 Jul; 6(4):182-6. PubMed ID: 18571105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quadrivalent meningococcal conjugate vaccines.
    Pace D; Pollard AJ; Messonier NE
    Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious disease. An ill wind, bringing meningitis.
    Roberts L
    Science; 2008 Jun; 320(5884):1710-5. PubMed ID: 18583588
    [No Abstract]   [Full Text] [Related]  

  • 12. Meningococcal disease control in countries of the African meningitis belt, 2013.
    Wkly Epidemiol Rec; 2014 May; 89(20):206-14. PubMed ID: 24864346
    [No Abstract]   [Full Text] [Related]  

  • 13. [Public health: the control of meningococcal disease in Quebec].
    De Wals P; Duval B; De Serres G; Boulianne N; Dionne M
    Med Sci (Paris); 2003 Oct; 19(10):1011-5. PubMed ID: 14613016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination Project-88. New Norwegian vaccine against type B meningitis--what happened?].
    Rød KA
    Fag Tidsskr Sykepleien; 1990 Jan; 78(1):27-31. PubMed ID: 2109367
    [No Abstract]   [Full Text] [Related]  

  • 15. A new conjugate meningococcal vaccine (Menveo).
    Med Lett Drugs Ther; 2010 Jul; 52(1343):59-60. PubMed ID: 20651639
    [No Abstract]   [Full Text] [Related]  

  • 16. Developmental strategy for a new Group A meningococcal conjugate vaccine (MenAfriVac
    Kulkarni PS; Jadhav SS; LaForce FM
    Hum Vaccin Immunother; 2018 May; 14(5):1103-1106. PubMed ID: 29048988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New Norwegian vaccine against meningeal infection].
    Bjunne G; Brandtzaeg P
    Sykepleien; 1988 May; 76(10):22-5. PubMed ID: 3388187
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].
    du Châtelet IP; Alonso JM; Taha MK
    Bull Soc Pathol Exot; 2002 Dec; 95(5):323-4; discussion 324-5. PubMed ID: 12696368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years.
    Galloway Y; Stehr-Green P; McNicholas A; O'Hallahan J
    Int J Epidemiol; 2009 Apr; 38(2):413-8. PubMed ID: 18988650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine introduction. The beginning of the end for Africa's devastating meningitis outbreaks?
    Roberts L
    Science; 2010 Dec; 330(6010):1466-7. PubMed ID: 21148362
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.